Ten cases of solid craniopharyngioma have been treated safely and effectively by gamma knife for a mean follow-up time of 13.9 months. Gamma radiosurgery was done as an initial radiotherapy to the residual or recurrent tumor after surgery in 8 cases. One recurrent tumor from surgery and conventional radiotherapy, and another tumor without previous treatment, have also been treated. Dose planning and dosimetry were performed using both axial and coronal MRIs. The tumor had a mean diameter of 21.1 mm and volume of 6.14 cm3. The tumor was treated with a mean maximum and marginal dose of 27.6 and 14.2 Gy respectively. The dose to the optic pathways is critical and was kept as low as possible which was calculated to be <13.0 Gy on average. As a result, marked shrinkage of the tumor in 7 and central necrosis in 3 tumors have been obtained without significant side effects.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.